Investing.com - Financial Markets Worldwide

Chengdu Olymvax Biopharmaceuticals Inc (688319)

Shanghai
Currency in CNY
20.32
-0.31(-1.50%)
Delayed Data·
688319 Scorecard
Full Analysis
Net income is expected to grow this year
688319 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
20.2120.79
52 wk Range
8.1124.60
Key Statistics
Edit
Bid/Ask
20.32 / 20.33
Prev. Close
20.63
Open
20.56
Day's Range
20.21-20.79
52 wk Range
8.11-24.6
Volume
3.24M
Average Volume (3m)
6.72M
1-Year Change
117.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688319 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 15
Trading at a low P/E ratio relative to near-term earnings growth
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Chengdu Olymvax Biopharmaceuticals Inc Company Profile

Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial. In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting. The company was founded in 2009 and is based in Chengdu, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
470
Market
China

Compare 688319 to Peers and Sector

Metrics to compare
688319
Peers
Sector
Relationship
P/E Ratio
214.8x−12.9x−0.5x
PEG Ratio
0.500.300.00
Price/Book
9.3x6.7x2.6x
Price / LTM Sales
14.1x20.1x3.3x
Upside (Analyst Target)
-3.7%43.4%
Fair Value Upside
Unlock−10.8%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.10%
Dividend Yield
-
Industry Median 1.51%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
87.49M / --
EPS Revisions
a
a
Unlock
Last 90 days

688319 Income Statement

FAQ

What Stock Exchange Does Chengdu Olymvax Biopharmaceuticals Trade On?

Chengdu Olymvax Biopharmaceuticals is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Chengdu Olymvax Biopharmaceuticals?

The stock symbol for Chengdu Olymvax Biopharmaceuticals is "688319."

What Is the Chengdu Olymvax Biopharmaceuticals Market Cap?

As of today, Chengdu Olymvax Biopharmaceuticals market cap is 8.37B.

What Is Chengdu Olymvax Biopharmaceuticals's Earnings Per Share (TTM)?

The Chengdu Olymvax Biopharmaceuticals EPS (TTM) is 0.10.

When Is the Next Chengdu Olymvax Biopharmaceuticals Earnings Date?

Chengdu Olymvax Biopharmaceuticals will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 688319 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Chengdu Olymvax Biopharmaceuticals Stock Split?

Chengdu Olymvax Biopharmaceuticals has split 0 times.

How Many Employees Does Chengdu Olymvax Biopharmaceuticals Have?

Chengdu Olymvax Biopharmaceuticals has 470 employees.

What is the current trading status of Chengdu Olymvax Biopharmaceuticals (688319)?

As of 08 Aug 2025, Chengdu Olymvax Biopharmaceuticals (688319) is trading at a price of 20.32, with a previous close of 20.63. The stock has fluctuated within a day range of 20.21 to 20.79, while its 52-week range spans from 8.11 to 24.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.